Prolonged Administration of Azacitidine With or Without Entinostat for Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Results of the US Leukemia Intergroup Trial E1905

Lignende værker

• Azacitidine with or without Entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study
  af: Prebet, Thomas, et al.
  Udgivet: (2015)
• Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukemia but does not add to prognostic utility of the revised IPSS
  af: Zeidan, Amer M, et al.
  Udgivet: (2014)
• Comparison of the Prognostic Utility of the Revised International Prognostic Scoring System and the French Prognostic Scoring System in Azacitidine-Treated Patients with Myelodysplastic Syndromes
  af: Zeidan, Amer M, et al.
  Udgivet: (2014)
• Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
  af: Prébet, Thomas, et al.
  Udgivet: (2013)
• Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin
  af: Fernandez, Hugo F., et al.
  Udgivet: (2011)